Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Studium Formulations is a specialty pharmaceutical company dedicated to the development of complex drug delivery systems and value-added generic products. The company leverages its proprietary formulation platforms to enhance the solubility, stability, and bioavailability of challenging therapeutic molecules, primarily through the 505(b)(2) regulatory pathway. Their core therapeutic focus includes high-growth areas such as ophthalmology, dermatology, and oncology. Studium provides end-to-end R&D services, ranging from initial formulation design and analytical development to clinical trial supply and commercial manufacturing. By utilizing advanced technologies like nano-emulsions and liposomes, the company aims to improve patient outcomes and compliance for established therapeutic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Studium Formulations.